Disruptive Technologies

A scientist test for COVID-19.

Memo to the president: Reimagining public health preparedness and response

By Daniel M. Gerstein | Disruptive Technologies

Introduction: Advice for a new administration facing difficult times

By John Mecklin | Climate Change, Disruptive Technologies, Nuclear Risk

A drive-thru coronavirus testing site.

What a MERS outbreak taught South Korea, why kids draw the coronavirus, and more: The best disruptive tech stories of 2020

By Matt Field | Disruptive Technologies

Nobel chemistry laureate Jennifer Doudna

Interview: Nobel chemistry laureate Jennifer Doudna on the promise and peril of the genetic editing revolution

By John Mecklin | Biosecurity

The placebo paradox: Why a COVID-19 vaccine trial participant might drop out

By Dawn Sinclair Shapiro | Biosecurity

Bioterrorism exercises

2005: The bioterrorist cookbook

By Malcolm Dando | Biosecurity

Martin Rees, Royal Astronomer and co-founder of Cambridge University’s Center for the Study of Existential Risk.

Buckle up: We are in for a bumpy ride. An interview with Royal Astronomer Martin Rees

By Rachel Bronson | Climate Change, Disruptive Technologies, Nuclear Weapons

A screen shot of the AMY1 gene from Arabidopsis thaliana, a small flowering plant widely used as a model organism in plant biology. (US government photo)

How to protect the world from ultra-targeted biological weapons

By Filippa Lentzos | Biosecurity, Cyber Security, Disruptive Technologies, Synthetic biology

Visitors check out an infinity chamber at the

Introduction: An innovative and determined future for the Bulletin of the Atomic Scientists

By John Mecklin | Climate Change, Disruptive Technologies, Nuclear Weapons

A team of Howard University researchers wants to know how disinformation impacts Black people

By Matt Field | Disruptive Technologies

MQ-9 Reaper unmanned aerial vehicle

We need a new international accord to control drone proliferation

By Agnes Callamard, James Rogers | Disruptive Technologies, Opinion

A COVID-19 test is collected.

Is emergency use authorization the best way to get a COVID-19 vaccine to the public?

By HyunJung Kim | Biosecurity